Defunct Company
Total Trials
7
As Lead Sponsor
6
As Collaborator
1
Total Enrollment
4,441
NCT01389102
Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms
Phase: Phase 3
Role: Lead Sponsor
Start: Dec 31, 2004
Completion: Nov 30, 2006
NCT00758953
Pain Associated With Endometriosis
Phase: Phase 2
Start: Feb 28, 2007
Completion: Jan 31, 2009
NCT00590590
Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort
Start: Oct 31, 2007
Completion: Jul 31, 2009
NCT00616330
Vaginal Infection Study
Start: Jan 31, 2008
Completion: Dec 31, 2009
NCT00694928
Vaginal Infection Study 2
Start: May 31, 2008
Completion: Nov 30, 2009
NCT01899846
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood
Phase: Phase 1
Start: Jul 31, 2013
Completion: Aug 31, 2014
NCT06832085
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Phase: Phase 4
Role: Collaborator
Start: Apr 30, 2025
Completion: Dec 31, 2026